Scientists at Oxford University say their experimental coronavirus vaccine has been shown in an early tri ...More

Scientists at Oxford University say their experimental coronavirus vaccine has been shown in an early trial to prompt a protective immune response in hundreds of people who got the shot. ...Less

Chief Executive Adar Poonawalla said in an interview after the shot was approved for emergency use in the ...More

Chief Executive Adar Poonawalla said in an interview after the shot was approved for emergency use in the world's second-most populous country, that exports might be possible after supplying the Indian government with an initial 100 million doses. ...Less

Pharma giant AstraZeneca on Saturday said that clinical trials for the AstraZeneca Oxford coronavirus vac ...More

Pharma giant AstraZeneca on Saturday said that clinical trials for the AstraZeneca Oxford coronavirus vaccine, AZD1222, have resumed in the UK following confirmation by the Medicines Health Regulatory Authority (MHRA) that the trials were safe. ...Less

The royal looked at a laboratory where samples from the clinical trial were being examined by researchers ...More

The royal looked at a laboratory where samples from the clinical trial were being examined by researchers. ...Less

According to the minutes of the meeting, the SEC has asked Serum to distribute clinical trial sites pan I ...More

According to the minutes of the meeting, the SEC has asked Serum to distribute clinical trial sites pan India, demarcate the phase II and Phase III part of the protocol. ET has seen the minutes of the meeting. ...Less

"Our team has been working closely with Dr Hill from Oxford University, and we are expecting to initiate ...More

"Our team has been working closely with Dr Hill from Oxford University, and we are expecting to initiate production of the vaccine in 2-3 weeks and produce 5 million doses per month for the first 6 months, following which, we hope to scale up production to 10 million doses per month," Serum Institute India (SII) CEO Adar Poonawalla said. ...Less

The trial data of a COVID-19 vaccine developed by AstraZeneca and Oxford University reveals that it is sa ...More

The trial data of a COVID-19 vaccine developed by AstraZeneca and Oxford University reveals that it is safe and induces immune response, with mild side effects in some participants, scientists announced on Monday. ...Less

"We are reviewing the situation and pausing India trials till AstraZeneca restarts the trials. We are fol ...More

"We are reviewing the situation and pausing India trials till AstraZeneca restarts the trials. We are following DCGI's instructions and will not be able to comment further on trials", said Adar Poonawala, CEO of Serum Institute of India in a statement. ...Less

Phase I human trials were completed in the UK. In India, the volunteers will be administered two doses of ...More

Phase I human trials were completed in the UK. In India, the volunteers will be administered two doses of the potential vaccine. Thereafter, four weeks apart, its safety and immunogenicity will be assessed. ...Less

The regulator had issued a show cause notice to SII on Wednesday evening asking it to explain why trials ...More

The regulator had issued a show cause notice to SII on Wednesday evening asking it to explain why trials shouldn’t be suspended. SII had said earlier that it would be continuing with trials despite the global halt. ...Less